Drug development and vaccine production were discussed at Near East University

Also available in: Türkçe

Added On: 17 December 2019, Tuesday, 14:47
Last Edited On: 18 December 2019, Wednesday, 15:31

Drug development and vaccine production were discussed at Near East University

Having been organized by Near East University Experimental Health Sciences Research Center, the Drug Development and Vaccine Production Symposium was held at Hall 101 of the Near East University Hospital.

The symposium provided a scientific platform for scholars from Near East University, Yeditepe University, Ege University, Izmir International Biomedicine and Genome Institute and Izmir Institute of Technology to deliver information on various topics regarding the issue.

Delivering the opening remarks of the symposium, the symposium coordinator Prof. Dr. K. Hüsnü Can Başer, the Director of the Health Sciences Graduate School of Near East University, stated that issues regarding both drug development and vaccine production would be discussed together at the symposium. Highlighting that some misinformation regarding vaccine had been delivered lately by media, he stated that they hoped the symposium would be a means to correct the misinformation.

Pharmaceutical raw materials evaluated in a wide perspective…

Making a presentation on the Role of Natural Resources in Pharmaceutical Research, Prof. Dr. Ihsan Çalış, the Dean of the Faculty of Pharmacy of Near East University, evaluated the use of medicinal plant extracts in the pharmaceutical industry from a broad perspective and talked about the potential of natural resources in pharmaceutical production. Delivering a lecture on medicine containing synthetic origin raw materials, Prof. Dr. Hülya Akgün, lecturer at the Department of Pharmaceutical Chemistry of Yeditepe University, addressed the synthesis methods used in drug investigations. Then, from the same university, Prof. Dr. Mine Yarım Yüksel delivered information about the in silico models used in drug design and explained the latest developments in the field of molecular docking.

Contemporary drugs developed for genetic and rare diseases were discussed…
Making a presentation on bio drugs, Prof. Dr. Mehmet Öztürk, Director of Izmir International Biomedicine and Genome Institute, delivered information about modern drugs developed for genetic and rare diseases and stated that these drugs were among the promising pharmaceutical products for personalized treatment.

Then, Prof. Dr. Erdal Bedir, lecturer at the Department of Bioengineering of the Faculty of Engineering of Izmir High Technology Institute, delivered information about the production of new pharmaceutical raw materials extracted from saponins by using semi-synthesis and bio-transformation methods. He also stated that his own factory produced compounds obtained from saponins extracted from the species of medicinal plant astragalus and his company exported these compounds to the USA.

Antibiotic Production was addressed…..
Asst. Prof. Dr. Güner Ekiz, lecturer at the Near East University Faculty of Pharmacy, delivered information about how to produce antibiotics through fermentation. Then, Prof. Dr. Nurettin Abacıoğlu, Chairman of the Department of Pharmacology of the Faculty of Pharmacy, made a presentation and delivered comprehensive information about clinical trials which constitute the most important stages in drug research. He said that such research processes, which constitute the most arduous stages of drug development, could last at least 15 years and cost millions of dollars.

Features of vaccines and the production of viral vaccine were addressed…
Prof. Dr. S. Ismet Delioğlu Gürhan, lecturer at the Department of Bioengineering of the Faculty of Engineering of Ege University, made a presentation and delivered information about the general characteristics of vaccines and the production of viral vaccines. Then, Veterinary Surgeon Nilay Unsal from the Dollvet Veterinary Vaccine, Medicine and Biological Material Manufacturer Company delivered information about the principles regarding vaccine development and bacterial vaccine production.